Cynthia Schwalm Caladrius Biosciences, Inc. (CLBS) insider trading activity

CLBS Quotes by TradingView

Cynthia Schwalm is Director of CALADRIUS BIOSCIENCES, INC.. Currently has a direct ownership of 49,201 shares of CLBS, which is worth approximately $173,187. The most recent transaction as insider was on Jan 09, 2024, when has been sold 19,480 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.2K
0% 3M change
65.54% 12M change
Total Value Held $173,187

Cynthia Schwalm Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2024
BUY
Grant, award, or other acquisition
-
19,480 Added 28.36%
49,201 Common Stock
Jan 09 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 40.22%
29,721 Common Stock
Jan 10 2022
BUY
Grant, award, or other acquisition
-
65,430 Added 30.97%
145,847 Common Stock
Jan 11 2021
BUY
Grant, award, or other acquisition
-
37,735 Added 31.94%
80,417 Common Stock

Also insider at

KDMN
Kadmon Holdings, Inc.
Director
GTHX
G1 Therapeutics, Inc. Healthcare
CS

Cynthia Schwalm

Director
Basking Ridge, NJ

Track Institutional and Insider Activities on CLBS

Follow CALADRIUS BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLBS shares.

Notify only if

Insider Trading

Get notified when an Caladrius Biosciences, Inc. insider buys or sells CLBS shares.

Notify only if

News

Receive news related to CALADRIUS BIOSCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CLBS